Results 151 to 160 of about 15,085 (211)

Exosomal NAMPT from Engineered Mesenchymal Stem Cells Mitigates Aortic Stenosis via Metabolic and Anti-Inflammatory Pathways. [PDF]

Int J Mol Sci
Kundu DK, Kiedrowski M, Gadd J, Gao M, Evan M, Wang Y, Yin L, Ohanyan V, Chilian WM, Dong F.   +9 more
europepmc   +1 more source

Nicotinamide phosphoribosyl transferase (NAMPT; NamPRT) [PDF]

Science-Business eXchange, 2013
openaire   +1 more source

Circadian rhythm disruption impairs ovarian follicular development via NAD⁺ metabolic reprogramming. [PDF]

EBioMedicine
Ying YY, Chen X, Yao SY, Chen RX, Ying Y, Qiu H, Xu QQ, Li ZY, Ye CQ, Qian YL, Liang HQ, Sun X, Zhang D.   +12 more
europepmc   +1 more source

Structural evolution of the selectivity clamp confers ADPR-PP specificity in Namat, a phage nicotinamide ADP-ribose transferase. [PDF]

Nucleic Acids Res
Lan M, Xu L, Han Y, Cui T, Qiao Z, Teng YB, Wang N, Bao H.   +7 more
europepmc   +1 more source

PAK4/NAMPT Inhibitor KPT-9274 [PDF]

, 2020
openaire   +1 more source

NAMPT modulates muscle fiber type transition in PAD myopathy via the cGMP-PKG signaling pathway. [PDF]

Biol Direct
Yang Q, Shi Y, Li W, Xiong X, Chen Q, Zheng M.   +5 more
europepmc   +1 more source

Nicotinamide N-Methyl Transferase (NNMT) Sustains Innate Sensitivity to NAMPT Inhibition in YAP-dependent Stem-like/Mesenchymal Prostate Cancer. [PDF]

Int J Biol Sci
Carreira ÁSA, Ciuffreda M, Thongon N, Haughey CM, Pickard A, Eddie SL, Steele RE, Cerri E, Belli R, Peroni D, Facen E, Caffa I, Ghanem M, Nencioni A, Lunardi A, Tebaldi T, Mills IG, Provenzani A.   +17 more
europepmc   +1 more source

Correlation between concentrations of NAMPT and NMNAT1 and the risk of upper respiratory infections in the island reef. [PDF]

World J Clin Cases
Gao GF, Yu J, Liu SY.
europepmc   +1 more source

Targeting TRAF3IP2 disrupts cellular energetics through inhibition of NAMPT in triple negative breast cancer. [PDF]

Sci Rep
Willingham K, Izadpanah A, Rashad Y, Reilich A, Daneshimehr F, Braun S, Alt EU, Izadpanah R.   +7 more
europepmc   +1 more source

Predictors and responses to varying durations of BTK inhibitor bridging therapy before anti-CD19 CAR-T cell therapy in patients with relapsed/refractory DLBCL. [PDF]

Front Immunol
Wang J, Cui R, Qi Y, Mu J, Li X, Li Q, Deng Q.   +6 more
europepmc   +1 more source